Generics makers, PBMs and other influential healthcare groups target Allergan patent deal
admin 10th October 2017 Uncategorised 0Top healthcare groups representing the generics industry, PBMs, payers, hospitals and more are criticizing Allergan’s tribal patent deal to protect blockbuster eye med Restasis.
More: Generics makers, PBMs and other influential healthcare groups target Allergan patent deal
Source: fierce